GHK-Cu stimulates fibroblasts to produce vascular endothelial growth factor (VEGF), the primary signal for new blood vessel formation
Clinical trials have used doses of 25-30 nmol/kg by IV infusion (Schneider-Helmert et al., 1981Subcutaneous administration and oral intestinal absorption have also been studied
Compounded medications are prepared by licensed pharmacies and are not FDA-approved drug products
This multi-oscillator system allows physiological processes to align with the appropriate time of day promoting activity, feeding, and catabolic processes during the biological daytime, and rest, fasting, and cellular repair during the biological night
For more information or advice, or to make a booking, get in touch with the team today,